• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将事件发生时间汇总数据纳入荟萃分析的实用方法:更新指南。

Practical methods for incorporating summary time-to-event data into meta-analysis: updated guidance.

作者信息

Tierney Jayne F, Burdett Sarah, Fisher David J

机构信息

MRC Clinical Trials Unit, Medical Research Council Clinical Trials Unit, University College London, London, UK.

出版信息

Syst Rev. 2025 Apr 10;14(1):84. doi: 10.1186/s13643-025-02752-z.

DOI:10.1186/s13643-025-02752-z
PMID:40211371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11984287/
Abstract

Our previous guide to estimating hazard ratios (HRs) from published summary (aggregate) data has become very widely used, but many still have difficulties knowing when and how to apply the methods. Informed by our increased experience of applying them across a range of settings, the queries we have received and results of a survey of Cochrane editors on the methods, we have updated the guidance comprehensively. Previously, we described a range of scenarios for deriving a HR and logrank variance (V) from published time-to-event analyses. They are incorporated in this update, together with clarification of ambiguities and additional scenarios. We also provide further guidance on extracting and using data from publications and Kaplan-Meier (KM) curves, raise some of the challenges, and discuss recent alternatives to the "Parmar" KM methods. A new calculations spreadsheet will perform all possible calculations given the data that are entered and includes new features to enhance the user experience. This updated guidance and associated spreadsheet represent valuable additional tools for those conducting meta-analyses based on published, summary, time-to-event data.

摘要

我们之前关于从已发表的汇总数据中估计风险比(HRs)的指南已被广泛使用,但许多人在了解何时以及如何应用这些方法时仍有困难。基于我们在一系列环境中应用这些方法的更多经验、收到的疑问以及对Cochrane编辑关于这些方法的调查结果,我们对该指南进行了全面更新。之前,我们描述了一系列从已发表的事件发生时间分析中得出HR和对数秩方差(V)的情景。它们被纳入本次更新中,同时对模糊之处进行了澄清并增加了其他情景。我们还提供了关于从出版物和Kaplan-Meier(KM)曲线中提取和使用数据的进一步指导,提出了一些挑战,并讨论了“Parmar”KM方法的最新替代方法。一个新的计算电子表格将根据输入的数据执行所有可能的计算,并包含增强用户体验的新功能。这份更新后的指南及相关电子表格为那些基于已发表的汇总事件发生时间数据进行荟萃分析的人提供了有价值的额外工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eeb/11984287/c5779a4f7cfe/13643_2025_2752_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eeb/11984287/c5779a4f7cfe/13643_2025_2752_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5eeb/11984287/c5779a4f7cfe/13643_2025_2752_Fig1_HTML.jpg

相似文献

1
Practical methods for incorporating summary time-to-event data into meta-analysis: updated guidance.将事件发生时间汇总数据纳入荟萃分析的实用方法:更新指南。
Syst Rev. 2025 Apr 10;14(1):84. doi: 10.1186/s13643-025-02752-z.
2
Estimating hazard ratios from published Kaplan-Meier survival curves: A methods validation study.从发表的 Kaplan-Meier 生存曲线估计风险比:方法验证研究。
Res Synth Methods. 2019 Sep;10(3):465-475. doi: 10.1002/jrsm.1362. Epub 2019 Jun 24.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Practical methods for incorporating summary time-to-event data into meta-analysis.将事件发生时间汇总数据纳入荟萃分析的实用方法。
Trials. 2007 Jun 7;8:16. doi: 10.1186/1745-6215-8-16.
5
A non-linear optimisation method to extract summary statistics from Kaplan-Meier survival plots using the published P value.一种使用已发表的 P 值从 Kaplan-Meier 生存图中提取汇总统计量的非线性优化方法。
BMC Med Res Methodol. 2020 Oct 30;20(1):269. doi: 10.1186/s12874-020-01092-x.
6
Implications of analysing time-to-event outcomes as binary in meta-analysis: empirical evidence from the Cochrane Database of Systematic Reviews.对荟萃分析中生存时间结局进行二元分析的影响:来自 Cochrane 系统评价数据库的实证证据。
BMC Med Res Methodol. 2022 Mar 20;22(1):73. doi: 10.1186/s12874-022-01541-9.
7
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.增强型生存数据分析:从已发表的 Kaplan-Meier 生存曲线中重建数据。
BMC Med Res Methodol. 2012 Feb 1;12:9. doi: 10.1186/1471-2288-12-9.
8
Exploring the characteristics, methods and reporting of systematic reviews with meta-analyses of time-to-event outcomes: a meta-epidemiological study.探索时间事件结局的系统评价与荟萃分析的特征、方法和报告:一项荟萃流行病学研究。
BMC Med Res Methodol. 2024 Nov 25;24(1):291. doi: 10.1186/s12874-024-02401-4.
9
Comparison of survival distributions in clinical trials: A practical guidance.临床试验中生存分布的比较:实用指南。
Clin Trials. 2020 Oct;17(5):507-521. doi: 10.1177/1740774520928614. Epub 2020 Jun 27.
10
A simple method for combining binomial counts or proportions with hazard ratios for evidence synthesis of time-to-event data.一种简单的方法,用于合并二项式计数或比例与风险比,以进行时间事件数据的证据综合。
Res Synth Methods. 2018 Sep;9(3):352-360. doi: 10.1002/jrsm.1301. Epub 2018 May 31.

本文引用的文献

1
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study.采用观察性研究设计评估的医疗保健结果与采用随机试验评估的结果比较:一项meta 流行病学研究。
Cochrane Database Syst Rev. 2024 Jan 4;1(1):MR000034. doi: 10.1002/14651858.MR000034.pub3.
2
A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials.前瞻性、适应性汇总分析(FAME)框架:来自随机试验的汇总数据。
PLoS Med. 2021 May 6;18(5):e1003629. doi: 10.1371/journal.pmed.1003629. eCollection 2021 May.
3
Making apples from oranges: Comparing noncollapsible effect estimators and their standard errors after adjustment for different covariate sets.
将橘子变成苹果:比较在调整不同协变量集后不可折叠的效应估计量及其标准误差。
Biom J. 2021 Mar;63(3):528-557. doi: 10.1002/bimj.201900297. Epub 2020 Dec 14.
4
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.辅助或早期挽救性放疗治疗局限性和局部进展性前列腺癌:汇总数据的前瞻性计划系统评价和荟萃分析。
Lancet. 2020 Oct 31;396(10260):1422-1431. doi: 10.1016/S0140-6736(20)31952-8. Epub 2020 Sep 28.
5
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.COVID-19 重症患者全身使用皮质类固醇与死亡率的关联:一项荟萃分析。
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
6
Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study.汇总数据和个体参与者数据方法在随机试验荟萃分析中的比较:一项观察性研究。
PLoS Med. 2020 Jan 31;17(1):e1003019. doi: 10.1371/journal.pmed.1003019. eCollection 2020 Jan.
7
RoB 2: a revised tool for assessing risk of bias in randomised trials.《随机对照试验偏倚风险评估工具2:修订版》
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.
8
Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.国家肺癌筛查试验中延长随访后的肺癌发病率和死亡率。
J Thorac Oncol. 2019 Oct;14(10):1732-1742. doi: 10.1016/j.jtho.2019.05.044. Epub 2019 Jun 28.
9
Estimating hazard ratios from published Kaplan-Meier survival curves: A methods validation study.从发表的 Kaplan-Meier 生存曲线估计风险比:方法验证研究。
Res Synth Methods. 2019 Sep;10(3):465-475. doi: 10.1002/jrsm.1362. Epub 2019 Jun 24.
10
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.转移性去势敏感性前列腺癌的前列腺放射治疗:STOPCAP 系统评价和荟萃分析。
Eur Urol. 2019 Jul;76(1):115-124. doi: 10.1016/j.eururo.2019.02.003. Epub 2019 Feb 28.